Applied Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -1198%. Total operating expenses were $74,528,000.

Profit Margin

Applied Therapeutics, Inc. (NASDAQ:APLT): Profit margin
2017 0 -4.28M
2018 0 -16.52M
2019 0 -45.39M
2020 0 -93.02M
2021 0 -104.61M
2022 0 -81.68M
2023 9.99M -119.76M -1198.47%

APLT Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
9.99M000000
Cost of revenue
353K441K415K380K23K00
Gross profit
9.64M-441K-415K-380K-23K00
Operating exp.
Research and development
53.90M55.63M62.57M61.78M32.35M11.47M3.70M
Selling and marketing
0000000
Total operating expenses
74.52M82.95M105.61M94.46M45.58M13.51M4.28M
Operating income
-64.53M-82.95M-105.61M-94.46M-45.58M-13.51M-4.28M
Other income (expenses), net
-55.22M442K34K505K69K-1.36M3K
Income before tax
-119.76M-82.50M-105.58M-93.96M-45.51M-16.52M-4.28M
Income tax expense
0-819K-970K-939K-116K4.86M-4.28M
Net income
-119.76M-81.68M-104.61M-93.02M-45.39M-16.52M-4.28M
Earnings per share
Basic EPS
-1.42-2.16-4.09-4.23-3.54-1.8-0.47
Diluted EPS
-1.42-2.16-4.09-4.23-3.54-1.8-0.47
Data sourceData sourceData sourceData sourceData source